Pfizer Inc. - Laporan Laba Rugi (TTM)

Pfizer Inc.
MX ˙ BMV ˙ US7170811035
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pfizer Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-27
2020
12-31
2021
04-04
2021
07-04
2021
10-03
2021
12-31
2022
04-03
2022
07-03
2022
10-02
2022
12-31
2023
04-02
2023
07-02
2023
10-01
2023
12-31
2024
03-31
2024
06-30
2024
09-29
2024
12-31
2025
03-30
2025
06-29
Revenue 32,334 41,651 46,084 55,119 68,877 81,288 92,433 101,275 99,878 101,175 93,154 78,420 69,274 59,554 55,947 56,224 60,433 63,627 62,464 63,833
Change (%) 28.81 10.64 19.61 24.96 18.02 13.71 9.57 -1.38 1.30 -7.93 -15.82 -11.66 -14.03 -6.06 0.50 7.49 5.29 -1.83 2.19
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 6,315 8,385 10,575 15,728 23,655 30,686 36,522 38,203 34,333 34,097 28,886 23,333 26,198 17,789 16,078 15,776 11,741 16,420 15,976 16,712
Change (%) 32.78 26.12 48.73 50.40 29.72 19.02 4.60 -10.13 -0.69 -15.28 -19.22 12.28 -32.10 -9.62 -1.88 -25.58 39.85 -2.70 4.61
% of Revenue 19.53 20.13 22.95 28.53 34.34 37.75 39.51 37.72 34.37 33.70 31.01 29.75 37.82 29.87 28.74 28.06 19.43 25.81 25.58 26.18
Gross Operating Profit 26,019 33,266 35,509 39,391 45,222 50,602 55,911 63,072 65,545 67,078 64,268 55,087 43,076 41,765 39,869 40,448 48,692 47,207 46,488 47,121
Change (%) 27.85 6.74 10.93 14.80 11.90 10.49 12.81 3.92 2.34 -4.19 -14.29 -21.80 -3.04 -4.54 1.45 20.38 -3.05 -1.52 1.36
% of Revenue 80.47 79.87 77.05 71.47 65.66 62.25 60.49 62.28 65.63 66.30 68.99 70.25 62.18 70.13 71.26 71.94 80.57 74.19 74.42 73.82
SG&A 11,006 11,418 11,454 11,676 9,714 9,562 9,400 10,038 11,325 12,200 13,258 13,394 13,561 13,836 13,908 14,139 14,155 14,771 14,333 14,005
Change (%) 3.74 0.32 1.94 -16.80 -1.56 -1.69 6.79 12.82 7.73 8.67 1.03 1.25 2.03 0.52 1.66 0.11 4.35 -2.97 -2.29
% of Revenue 34.04 27.41 24.85 21.18 14.10 11.76 10.17 9.91 11.34 12.06 14.23 17.08 19.58 23.23 24.86 25.15 23.42 23.21 22.95 21.94
R&D 8,084 8,709 9,184 9,589 9,972 10,360 10,667 11,243 11,260 11,428 11,621 11,435 11,420 10,679 10,665 10,712 10,595 10,822 10,521 10,289
Change (%) 7.73 5.45 4.41 3.99 3.89 2.96 5.40 0.15 1.49 1.69 -1.60 -0.13 -6.49 -0.13 0.44 -1.09 2.14 -2.78 -2.21
% of Revenue 25.00 20.91 19.93 17.40 14.48 12.74 11.54 11.10 11.27 11.30 12.48 14.58 16.49 17.93 19.06 19.05 17.53 17.01 16.84 16.12
OpEx 28,868 31,860 34,570 40,399 46,853 54,308 60,266 63,065 60,353 61,334 57,642 52,401 55,776 47,037 45,589 45,688 41,685 47,299 46,019 46,098
Change (%) 10.36 8.51 16.86 15.98 15.91 10.97 4.64 -4.30 1.63 -6.02 -9.09 6.44 -15.67 -3.08 0.22 -8.76 13.47 -2.71 0.17
% of Revenue 89.28 76.49 75.02 73.29 68.02 66.81 65.20 62.27 60.43 60.62 61.88 66.82 80.52 78.98 81.49 81.26 68.98 74.34 73.67 72.22
Operating Income 3,466 9,791 11,514 14,720 22,024 26,980 32,167 38,210 39,525 39,841 35,512 26,019 13,498 12,517 10,358 10,536 18,748 16,328 16,445 17,735
Change (%) 182.49 17.60 27.84 49.62 22.50 19.23 18.79 3.44 0.80 -10.87 -26.73 -48.12 -7.27 -17.25 1.72 77.94 -12.91 0.72 7.84
% of Revenue 10.72 23.51 24.98 26.71 31.98 33.19 34.80 37.73 39.57 39.38 38.12 33.18 19.48 21.02 18.51 18.74 31.02 25.66 26.33 27.78
Interest Expense -1,517 -1,449 -1,395 -1,343 -1,322 -1,291 -1,277 -1,254 -1,241 -1,238 -1,234 -1,450 -1,834 -2,209 -2,681 -2,951 -3,039 -3,091 -2,955 -2,831
Change (%) -4.48 -3.73 -3.73 -1.56 -2.34 -1.08 -1.80 -1.04 -0.24 -0.32 17.50 26.48 20.45 21.37 10.07 2.98 1.71 -4.40 -4.20
% of Revenue -4.69 -3.48 -3.03 -2.44 -1.92 -1.59 -1.38 -1.24 -1.24 -1.22 -1.32 -1.85 -2.65 -3.71 -4.79 -5.25 -5.03 -4.86 -4.73 -4.44
Net Income 7,977 9,159 10,681 12,756 19,432 21,979 24,966 29,308 29,771 31,372 29,051 21,473 10,482 2,119 -309 -2,595 4,252 8,031 7,883 10,752
Change (%) 14.82 16.62 19.43 52.34 13.11 13.59 17.39 1.58 5.38 -7.40 -26.09 -51.19 -79.78 -114.58 739.81 -263.85 88.88 -1.84 36.39
% of Revenue 24.67 21.99 23.18 23.14 28.21 27.04 27.01 28.94 29.81 31.01 31.19 27.38 15.13 3.56 -0.55 -4.62 7.04 12.62 12.62 16.84

Source: Capital IQ

Other Listings
IT:1PFE € 20.98
CO:PFE
AT:PFE
PE:PFE
BG:PFE
GB:0Q1N US$ 24.74
DE:PFE € 21.13
CL:PFECL
KZ:PFE_KZ US$ 24.56
US:PFE US$ 24.88
GB:PFED
CL:PFE
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista